Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Lutris Pharma Information
Geographic Data
Address: 27 Habarzel St
City:
State: NE
Zip: None
Country: US
Financial Info
Stage:
grant
Raised Last:
$5M
Raised Total:$5M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness. The company develops the topical B-Raf inhibitor LUT014, a proprietary small molecule that allows administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects. Lutris Pharma was established in 2015 and is based in Tel Aviv-yafo, Israel.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Grant | 1 | $5M |
California Institute for Regenerative Medicine California Institute for Regenerative Medicine |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
